Mustafa Dinc, born in 1973 in Freising, Bavaria, has accumulated 24 years of quality management experience, eight years dedicated to the automotive industry, and 16 years in medical technology. Additionally, he has approximately eight years of expertise in the registration of medical products (e.g., CE, FDA, CFDA).

​

Since 2009, he has specialized in quality and regulatory management within the medical technology sector, devising sophisticated and practical solutions tailored to companies of various sizes. He has extensive project experience spanning automotive, mechanical engineering, and medical technology domains, covering active and passive medical devices ranging from Class I to III. 

​

Key focuses in his recent projects include process validation, quality, and risk management (compliant with DIN EN ISO 14971, 13485, and 9001, MDD, MDR 2017/745, MDSAP), remediation, NC-remediation, complaint management, audit execution, process enhancement, and regulatory affairs (Class I-III), including clinical affairs. 

​

Through his latest project, which involved implementing and executing Post-Market Surveillance as per MDR (Medical Device Regulation) Articles 83 to 92, Article 10, Article 15, and Article 61 (Clinical Evaluation Report), he has acquired profound practical knowledge in implementing MDR, ISO 13485:2016, and MDSAP, which he has been able to impart to others.

​

Mustafa Dinc completed his MBA in Compliance and Risk Management with the submission of his Master's thesis on the topic: 'The German Supply Chain Due Diligence Act (LkSG) – Impacts and Recommendations for Action' in mid-March 2025. The evaluation of the thesis is still pending.